President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency’s director was forced out.
O’Neill, Kennedy’s deputy at the Department of Health and Human Services, will supplant Susan Monarez, a longtime government scientist who had been the CDC director for less than a month.
Monarez’s lawyers said she refused “to rubber-stamp unscientific, reckless directives and fire dedicated health experts.”
It’ll be interesting because the FDA is considered to be very strict internationally, and when a drug is approved here it a lot easier to get it approved in other countries. That is going to change very soon.